Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fairhead

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Biorxiv : the Preprint Server for Biology|May 15, 2024
High-throughput crystallographic fragment screening of Zika virus NS3 HelicaseAndre S Godoy, Nathalya C M R Mesquita, Gabriela Dias Noske, et al.
Nucleic Acids Research|April 28, 2023
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonucleaseAndre Schutzer Godoy, Aline Minalli Nakamura, Alice Douangamath, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Journal of the American Chemical Society|May 8, 2019
Rapid Covalent-Probe Discovery by Electrophile-Fragment ScreeningEfrat Resnick, Anthony Bradley, Jinrui Gan, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral responseAlpha A Lee, Isabelle Amick, Jasmin C Aschenbrenner, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Nature Communications|October 8, 2025
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Biorxiv : the Preprint Server for Biology|May 15, 2024
High-throughput crystallographic fragment screening of Zika virus NS3 HelicaseAndre S Godoy, Nathalya C M R Mesquita, Gabriela Dias Noske, et al.
Nucleic Acids Research|April 28, 2023
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonucleaseAndre Schutzer Godoy, Aline Minalli Nakamura, Alice Douangamath, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Journal of the American Chemical Society|May 8, 2019
Rapid Covalent-Probe Discovery by Electrophile-Fragment ScreeningEfrat Resnick, Anthony Bradley, Jinrui Gan, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral responseAlpha A Lee, Isabelle Amick, Jasmin C Aschenbrenner, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Nature Communications|October 8, 2025
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 4